Skip to main content
Article
Pyrrolizidine Esters and Amides as 5-HT4 Receptor Agonists and Antagonists
Journal of Medicinal Chemistry
  • Daniel Becker, Loyola University Chicago
  • Daniel L. Flynn
  • Alan E. Moormann
  • Roger Nosal
Document Type
Article
Publication Date
2-9-2006
Pages
1125–1139
Publisher Name
American Chemical Society
Disciplines
Abstract

A series of pyrrolizidine esters, amides, and ureas was prepared and tested for 5-HT(4) and 5-HT(3) receptor binding, 5-HT(4) receptor agonism in the rat tunica muscularis mucosae (TMM) assay, and for 5-HT(3) receptor-mediated functional antagonism in the Bezold-Jarisch reflex assay. Several pyrrolizidine derivatives were identified with high affinity for the 5-HT(4) receptor, including benzamide 12a (SC-53116), a potent and selective 5-HT(4) partial agonist that exhibits efficacy in promoting antral contractions and activity in promoting gastric emptying in canine models. Also discovered were 5-HT(4) receptor antagonists, including imidazopyridine amide 12h (SC-53606), which is a potent and selective 5-HT(4) receptor antagonist with a pA(2) value of 8.13 in the rat TMM assay. N-Methyl indole ester 13d was identified as a potent 5-HT(4) antagonist with a pA(2) value of 8.93. High selectivity was observed for these pyrrolizidine derivatives versus other monoamine receptors, including 5-HT(1), 5-HT(2), D(1), D(2), alpha(1), alpha(2), and beta receptors.

Comments
Author Posting © American Chemical Society, 2006. This is the author's version of the work. It is posted here by permission of American Chemical Society for personal use, not for redistribution. The definitive version was published in Journal of Medicinal Chemistry, Volume 49, Issue 3, February 9, 2006. http://dx.doi.org/10.1021/jm0509501
Creative Commons License
Creative Commons Attribution-Noncommercial-No Derivative Works 3.0
Citation Information
Daniel Becker, Daniel L. Flynn, Alan E. Moormann and Roger Nosal. "Pyrrolizidine Esters and Amides as 5-HT4 Receptor Agonists and Antagonists" Journal of Medicinal Chemistry Vol. 49 Iss. 3 (2006)
Available at: http://works.bepress.com/daniel_p_becker/9/